![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Fractionated dose 177Lu-PSMA-617 in patients with mCRPC (VJOncology) View |
![]() |
177Lu-PSMA-617 radionuclide therapy in mCRPC (VJOncology) View |
![]() |
177Lu-PSMA-617 for prostate cancer: TheraP, VISION, UpFrontPSMA and LuTectomy (VJOncology) View |
![]() |
TheraP Trial and Effectiveness of Lu-PSMA-617 (Grand Rounds in Urology) View |
![]() |
A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients (ecancer) View |
![]() |
Lutetium-177 PSMA scanning for prostate cancer (ecancer) View |
![]() |
VISION study (European Association of Urology) View |
![]() |
Phase I/II dose-escalation study of 225Ac-J591 in progressive mCRPC (VJOncology) View |
![]() |
Oncological Value of Lutetium-177-PSMA Therapy for mCRPC (KPS-APSU Joint International Symposium) View |
![]() |
LuPSMA: The Newest Treatment Class for Advanced Prostate Cancer (ProsTIC TV) View |